期刊文献+

全身化疗联合高聚金葡素或香菇多糖治疗非小细胞性恶性胸腔积液的研究 被引量:5

Study of highly agglutinative Staphyloccocin or lentinan combined with chemotherapy on malignant pleural effusion of non-small cell lung cancer
下载PDF
导出
摘要 目的观察全身化疗联合高聚金葡素或香菇多糖胸腔注射治疗肺非小细胞性恶性胸腔积液的疗效和毒副反应。方法60例患者随机分为A、B2组,均行全身NP化疗。A组胸腔内注射高聚金葡素,B组胸腔注射香菇多糖。观察2组治疗前后胸腔积液控制情况、生活质量及毒副反应情况。结果A、B2组总有效率分别为80%和77%(P>0.05)。2组毒性反应轻微,均可耐受,A组发热和胸痛发生率高于B组(P<0.05)。A、B2组中分别有80%和90%的患者生活质量得到提高,2组间无明显差异。结论全身化疗联合高聚金葡素或香菇多糖胸腔注射治疗肺非小细胞性恶性胸腔积液的疗效均显著,可明显改善患者生活质量,且毒性反应轻微,可耐受。 Objective It is to observe the influence and toxicity of highly agglutinative staphyloceocin or lentinan combined with chemotherapy in the treatment for malignant pleural effusion of non-small cell lung cancer. Methods Sixty patients were randomly divided into two groups: A group and B group. After chemotherapy of navelbine and cisplatin, the patients were injected highly agglutinative staphyloccocin in group A to thoracic cavity, while lentinan in group B. The therapeutic effect, life quality and adverse reactions were observed. Results The total effective rates (complete and partial remission) were 80 % and 77 % respectively in group A and group B ( P 〉 0.05 ). The incidences of adverse reactions was lower in both groups. But the incidences of fever and stethalgia were higher in group A than that in group B ( P 〈 0.05 ). There were 90 % and 80 % patients whose life qualities were improved in group A and group B respectively. Conclusion Both highly agglutinative staphyloccocin and lentinan combined with chemotherapy are effective for malignant pleural effusion of non-small cell lung cancer with mild side effects.
出处 《现代中西医结合杂志》 CAS 2008年第36期5561-5562,5713,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 高聚金葡素 香菇多糖 恶性胸腔积液 highly agglutinative staphyloccoein lentinan malignant pleural effusion
  • 相关文献

参考文献5

二级参考文献19

共引文献53

同被引文献42

  • 1兰箭,张和生.顺铂联合斯奇康胸腔内注入治疗恶性胸腔积液28例[J].中国药业,2004,13(8):65-66. 被引量:4
  • 2陆筱灵,左云,刘卓.胸腔闭塞引流后灌注顺铂及天地欣治疗恶性胸腔积液临床观察[J].中国肿瘤临床与康复,2006,13(4):362-363. 被引量:12
  • 3Kilickap S,Yalcin S,Ates O,et al.The first line systemic chemotherapy in metastatic gastric carcinoma:A comparison of docetaxel,cisplatin and fluorouracil (DCF) versus cisplatin and fluorouracil (CF);versus epirubicin,cisplatin and fluorouracil (ECF) regimens in clinical setting.Hepatogastroenterology.2011 Jan-Feb;58(105):208-212.
  • 4Webb A.Cunningham D,Scarffe JH,et a1.Randomized trial comparing epirubicin,eisplatin,and fluorouracil verfus fluorou-racil,doxorubicin,and methotrexate in advanced esophagogastrlc cancer.J Clin Oncol,1997,15(1):261-267.
  • 5Van Cutsem E.Moiseyenko VM,Tjulandin S,et a1.Phase nl study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group.J Clin Oncol,2006,24(31):4991.4997.
  • 6Rivera F,Carrato A,Grávalos C,et al.Recommendations on current approach to gastric cancer.Clin Transl Oncol.2009 Aug;11(8):518-25.
  • 7Both AD,Fazio N,Stupp R,et a1.Docetaxel,cisplatin,and fluorouracil;docetaxel and cisplatin;and epirubicin,cisplatin,and fluorouracil as systemic treatment for advanced gastric carcinoma:a randomized phase II trial of the Swiss Group for Clinical Cancer Research.J Clin Oncol,2007,25(22):3217-3223.
  • 8Overman MJ,Kazmi SM,Jhamb J,et al.Weekly docetaxel,cisplatin,and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer.Cancer.2010 Mar 15;116(6):1446-1453.
  • 9Ahmad A,Sakr WA,Rahman KM.Anticancer properties of indole compounds:mechanism of apoptosis induction and role in chemotherapy.Curr Drug Targets.2010,11(6):652-666.
  • 10孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生社出版.2007.152.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部